wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38155201-799F0EB8-1D13-4853-AB1E-E6EE80306AA9
Q38155201-799F0EB8-1D13-4853-AB1E-E6EE80306AA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155201-799F0EB8-1D13-4853-AB1E-E6EE80306AA9
Second-line systemic therapy for metastatic urothelial carcinoma of the bladder.
P2860
Q38155201-799F0EB8-1D13-4853-AB1E-E6EE80306AA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155201-799F0EB8-1D13-4853-AB1E-E6EE80306AA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
068f9451b93e2fab58d161ce4031f4e5e68b656d
P2860
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].